Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/17/2021 06/18/2021 06/21/2021 06/22/2021 06/23/2021 Date
214.2(c) 212.42(c) 226.09(c) 236.49(c) 229.5(c) Last
2 107 671 2 256 063 1 849 836 2 032 724 2 707 838 Volume
+5.08% -0.83% +6.44% +4.60% -2.96% Change
More quotes
Estimated financial data (e)
Sales 2021 12 387 M 14 790 M 14 790 M
Net income 2021 7 065 M 8 435 M 8 435 M
Net cash position 2021 7 669 M 9 157 M 9 157 M
P/E ratio 2021 6,80x
Yield 2021 -
Sales 2022 10 740 M 12 823 M 12 823 M
Net income 2022 6 903 M 8 242 M 8 242 M
Net cash position 2022 13 186 M 15 744 M 15 744 M
P/E ratio 2022 7,58x
Yield 2022 -
Capitalization 46 467 M 55 429 M 55 479 M
EV / Sales 2021 3,13x
EV / Sales 2022 3,10x
Nbr of Employees 2 200
Free-Float 87,3%
More Financials
Company
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer... 
More about the company
Ratings of BioNTech SE
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about BIONTECH SE
08:13aMARKET CHATTER : Pfizer, BioNTech COVID-19 Vaccine Found to be 90% Effective Aga..
MT
07:41aMARKET CHATTER : Pfizer-BioNTech Vaccine 'Very Effective' Against Delta Variant,..
MT
06:33aEUROPEAN MIDDAY BRIEFINGá : Banks Lead Stocks Higher -2-
DJ
06:31aNORTH AMERICAN MORNING BRIEFING : Stock Futures Tick Up Ahead of Jobless Claims ..
DJ
12:31aEMEA MORNING BRIEFINGá : Uncertainty Over Fed -2-
DJ
06/23ADRs End Mostly Higher; XPeng, BioNTech Among Companies Actively Trading
DJ
06/23Nasdaq logs second straight closing high
RE
06/23MODERNAá : NIH begins clinical trial testing COVID-19 vaccine in pregnant women
RE
06/23European ADRs Edge Higher in Wednesday Trading
MT
06/23US' CDC To Study Possible Link Between Heart Inflammation And Pfizer/BioNTech..
MT
06/23BIONTECHá : EMA - Two additional manufacturing sites for BioNTech Pfizer's COVID..
AQ
06/23GLOBAL MARKETS LIVE : Microsoft, Morgan Stanley, Heineken, Twitter, AstraZeneca...
06/23SIEMENSá : To Provide Technology Support For BioNTech's Vaccine Production Sites
MT
06/23Today on Wall Street: We shall not be ruled by inflation fears
06/23Siemens, BioNTech to Expand Vaccine Production Collaboration
DJ
More news
News in other languages on BIONTECH SE
03:37aMerkel verteidigt Patentschutz für Corona-Impfstoffe
06/23LONDON : Impfungen haben bereits mehr als 14á000 Leben gerettet
06/23Siemens y BioNTech amplían colaboración para producción de vacunas
06/23SIEMENSá : collaboration industrielle renforcée avec BioNTech
06/23Siemens und Biontech bauen Covid-19-Impfstoff-Zusammenarbeit aus
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 192,39 €
Average target price 148,37 €
Spread / Average Target -22,9%
EPS Revisions
Managers and Directors
NameTitle
Ugur Sahin Chief Executive Officer
Sierk P÷tting Chief Operating & Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Ízlem TŘreci Chief Medical Officer
Christoph Huber Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BIONTECH SE181.53%55 429
GILEAD SCIENCES, INC.14.40%83 591
WUXI APPTEC CO., LTD.36.51%69 433
REGENERON PHARMACEUTICALS9.66%54 864
VERTEX PHARMACEUTICALS-20.66%48 542
BEIGENE, LTD.32.45%31 674